First Time Loading...

Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 120 JPY -0.95% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

260.9B
+14%
Assets
Growth Rates:
1 Year
+18%
3 Years
-3%
5 Years
+22%
7 Years
+40%
10 Years
+51%
40.9B
+28%
Liabilities
Growth Rates:
1 Year
+50%
3 Years
-17%
5 Years
+31%
7 Years
+39%
10 Years
+36%
220B
+12%
Equity
Growth Rates:
1 Year
+13%
3 Years
+0%
5 Years
+21%
7 Years
+40%
10 Years
+54%

Balance Sheet Decomposition
Kissei Pharmaceutical Co Ltd

260.9B
Assets
40.9B
Liabilities
260.9B
Assets
40.9B
Liabilities
Current Assets 104.6B
Cash & Short-Term Investments 45.9B
Receivables 28.7B
Other Current Assets 29.9B
Non-Current Assets 156.4B
Long-Term Investments 106.4B
PP&E 24.9B
Intangibles 2B
Other Non-Current Assets 23.2B
Current Liabilities 17.7B
Accounts Payable 4.9B
Accrued Liabilities 1.9B
Other Current Liabilities 10.9B
Non-Current Liabilities 23.2B
Other Non-Current Liabilities 23.2B

Balance Sheet
Kissei Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
27 241
25 666
27 109
24 371
26 325
36 329
20 456
30 013
25 893
22 894
Cash Equivalents
27 241
25 666
27 109
24 371
26 325
36 329
20 456
30 013
25 893
22 894
Short-Term Investments
25 132
24 476
21 039
23 288
23 039
23 342
23 998
23 139
23 706
23 039
Total Receivables
23 674
24 965
24 729
28 872
26 962
19 462
23 058
22 806
22 779
28 679
Accounts Receivables
23 674
24 965
24 729
28 872
26 962
19 462
23 058
22 806
22 779
28 679
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
14 646
17 375
16 724
15 932
13 963
13 438
20 118
18 987
22 798
26 296
Other Current Assets
6 668
7 569
7 617
5 700
5 493
4 106
5 335
4 397
5 465
3 643
Total Current Assets
97 361
100 051
97 218
98 163
95 782
96 677
92 965
99 342
100 641
104 551
PP&E Net
26 852
26 758
26 308
26 396
25 503
24 605
24 290
24 074
24 579
24 861
PP&E Gross
26 852
26 758
26 308
26 396
25 503
24 605
24 290
24 074
24 579
24 861
Accumulated Depreciation
38 362
38 751
39 342
40 728
41 992
43 365
44 105
44 138
44 205
44 926
Intangible Assets
785
813
1 845
1 716
1 519
1 511
1 640
1 569
1 507
1 683
Goodwill
0
0
0
0
0
0
0
0
0
309
Note Receivable
134
0
119
98
118
36
14
3
5
5
Long-Term Investments
54 407
62 363
58 344
81 194
86 958
105 158
138 133
96 631
74 769
106 361
Other Long-Term Assets
1 945
3 245
2 967
3 254
3 642
3 807
11 819
16 468
19 699
23 159
Other Assets
0
0
0
0
0
0
0
0
0
309
Total Assets
181 484
N/A
193 345
+7%
186 801
-3%
210 821
+13%
213 522
+1%
231 794
+9%
268 861
+16%
238 087
-11%
221 200
-7%
260 929
+18%
Liabilities
Accounts Payable
6 045
5 829
4 849
4 894
4 347
5 237
7 909
4 104
4 617
4 893
Accrued Liabilities
2 169
2 210
2 113
2 251
1 989
1 866
1 830
1 721
1 679
1 856
Short-Term Debt
1 730
1 730
1 730
1 730
1 730
1 730
1 730
1 640
1 490
0
Current Portion of Long-Term Debt
149
150
114
106
144
152
144
116
145
1 340
Other Current Liabilities
8 841
9 689
6 850
8 467
5 591
8 039
6 632
11 163
7 026
9 574
Total Current Liabilities
18 934
19 608
15 656
17 448
13 801
17 024
18 245
18 744
14 957
17 663
Long-Term Debt
1 614
1 591
1 732
2 097
2 201
386
304
227
317
0
Deferred Income Tax
7 338
7 395
5 645
9 935
11 388
17 191
28 480
16 259
10 426
21 188
Minority Interest
279
265
329
390
444
504
638
794
914
1 107
Other Liabilities
2 878
6 626
5 985
5 249
3 425
4 223
1 879
677
686
942
Total Liabilities
31 043
N/A
35 485
+14%
29 347
-17%
35 119
+20%
31 259
-11%
39 328
+26%
49 546
+26%
36 701
-26%
27 300
-26%
40 900
+50%
Equity
Common Stock
24 356
24 356
24 356
24 356
24 356
24 356
24 356
24 356
24 356
24 356
Retained Earnings
95 565
96 230
101 755
102 834
106 026
106 461
109 270
118 183
125 576
127 310
Additional Paid In Capital
24 254
24 247
24 226
24 226
24 226
24 226
24 226
24 226
24 226
24 226
Unrealized Security Profit/Loss
21 517
0
21 268
36 752
40 326
50 706
74 351
45 095
30 393
52 782
Treasury Stock
16 591
0
12 838
11 607
11 607
11 608
12 911
12 912
12 912
13 209
Other Equity
1 340
1 729
1 313
859
1 064
1 675
23
2 438
2 261
4 564
Total Equity
150 441
N/A
157 860
+5%
157 454
0%
175 702
+12%
182 263
+4%
192 466
+6%
219 315
+14%
201 386
-8%
193 900
-4%
220 029
+13%
Total Liabilities & Equity
181 484
N/A
193 345
+7%
186 801
-3%
210 821
+13%
213 522
+1%
231 794
+9%
268 861
+16%
238 087
-11%
221 200
-7%
260 929
+18%
Shares Outstanding
Common Shares Outstanding
49
49
48
47
47
47
46
46
46
44

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.